Passifs Courants Changement Date
AstraZeneca USD 32.57B 1.95B 2026-03
Galapagos EUR 152.86M 213.7M 2025-12
Genmab DKK 1.43B 686M 2025-12
GlaxoSmithKline GBP 22.43B 1.04B 2026-03
GRIFOLS EUR 2.02B 135.85M 2025-12
Hikma Pharmaceutical USD 1.45B 603M 2025-12
Qiagen NV USD 512.14M 461.26M 2025-12
UCB EUR 4.4B 470M 2025-12